Conducting clinical research in a resource-constrained setting: lessons from a longitudinal cohort study in The Gambia.
child health
public health
vaccines
Journal
BMJ global health
ISSN: 2059-7908
Titre abrégé: BMJ Glob Health
Pays: England
ID NLM: 101685275
Informations de publication
Date de publication:
08 2021
08 2021
Historique:
received:
27
05
2021
accepted:
30
07
2021
entrez:
17
8
2021
pubmed:
18
8
2021
medline:
13
10
2021
Statut:
ppublish
Résumé
Clinical research conducted to Good Clinical Practice (GCP) standards is increasingly being undertaken in resource-constrained low-income and middle-income countries (LMICs) settings. This presents unique challenges that differ from those faced in high-income country (HIC) contexts, due to a dearth of infrastructure and unique socio-cultural contexts. Field experiences by research teams working in these LMIC contexts are thus critical to advancing knowledge on successful research conduct in these settings. The Medical Research Council Unit The Gambia at London School of Hygiene and Tropical Medicine has operated in The Gambia, a resource-constrained LMIC for over 70 years and has developed numerous research support platforms and systems. The unit was the lead clinical collaborator in a recently completed Expanded Program on Immunization Consortium (EPIC) study, involving a multicountry collaboration across five countries including the USA, Canada, Belgium, Papua New Guinea and The Gambia. The EPIC study recruited and completed follow-up of 720 newborn infants over 2 years. In this paper, we provide in-depth field experience covering challenges faced by the Gambian EPIC team in the conduct of this study. We also detail some reflections on these challenges. Our findings are relevant to the international research community as they highlight practical day-to-day challenges in conducting GCP standard clinical research in resource-constrained LMIC contexts. They also provide insights on how study processes can be adapted early during research planning to mitigate challenges.
Identifiants
pubmed: 34400549
pii: bmjgh-2021-006419
doi: 10.1136/bmjgh-2021-006419
pmc: PMC8370547
pii:
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Medical Research Council
ID : MC_EX_MR/P024270/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UP_A900_1122
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00026/2
Pays : United Kingdom
Informations de copyright
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Vaccine. 2016 Jun 17;34(29):3335-41
pubmed: 27195759
N Engl J Med. 1997 Oct 2;337(14):1003-5
pubmed: 9309109
Lancet. 2015 Jan 31;385(9966):420
pubmed: 25608754
Am J Trop Med Hyg. 2013 Mar;88(3):414-9
pubmed: 23468356
PLoS One. 2017 Feb 24;12(2):e0170739
pubmed: 28234894
BMC Public Health. 2010 Sep 17;10:556
pubmed: 20849580
J Infect Dis. 2018 May 18;217(suppl_1):S16-S23
pubmed: 29788343
Int J Equity Health. 2018 Mar 22;17(1):37
pubmed: 29566721
PLoS One. 2016 Aug 15;11(8):e0160464
pubmed: 27525652
BMJ Open. 2020 Jul 19;10(7):e035311
pubmed: 32690506
Lancet Glob Health. 2016 Aug;4(8):e559-67
pubmed: 27443781
BMJ. 1999 Aug 14;319(7207):438-41
pubmed: 10445930
J Infect Dis. 2018 May 18;217(suppl_1):S65-S74
pubmed: 29788348
Front Pediatr. 2020 Apr 30;8:197
pubmed: 32426309
Global Health. 2019 Mar 26;15(1):23
pubmed: 30914049
Clin Infect Dis. 2015 Nov 15;61 Suppl 5:S416-21
pubmed: 26553669